These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16226808)

  • 1. Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes.
    Delgado TC; Tomaz AI; Correia I; Costa Pessoa J; Jones JG; Geraldes CF; Castro MM
    J Inorg Biochem; 2005 Dec; 99(12):2328-39. PubMed ID: 16226808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes.
    Correia I; Costa Pessoa J; Duarte MT; Henriques RT; Piedade MF; Veiros LF; Jakusch T; Kiss T; Dörnyei A; Castro MM; Geraldes CF; Avecilla F
    Chemistry; 2004 May; 10(9):2301-17. PubMed ID: 15112220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
    Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
    Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of hydroxyurea with oxovanadium(V) ions in acidic aqueous solution.
    Gabricević M; Besić E; Birus M; Zahl A; Eldik Rv
    J Inorg Biochem; 2006 Oct; 100(10):1606-13. PubMed ID: 16842853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of p-chlorotoluene and cyclohexene catalysed by polymer-anchored oxovanadium(IV) and copper(II) complexes of amino acid derived tridentate ligands.
    Maurya MR; Kumar M; Kumar A; Costa Pessoa J
    Dalton Trans; 2008 Aug; (32):4220-32. PubMed ID: 18682861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
    Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
    J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
    Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
    Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
    J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
    J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
    Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
    J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic properties, redox behavior, and interactions with H2O2 of pH-sensitive hydroxyphenyl-1,2,4-triazole-based oxovanadium(V) complexes.
    Browne WR; Ligtenbarg AG; de Boer JW; van den Berg TA; Lutz M; Spek AL; Hartl F; Hage R; Feringa BL
    Inorg Chem; 2006 Apr; 45(7):2903-16. PubMed ID: 16562946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, spectroscopic characterization and reactivity studies of oxovanadium(IV) complexes with bulky N,N'-polymethylenebis(3,5-(t)Bu(2)salicylaldimine) ligands.
    Kasumov VT; Köksal F; Aslanoglu M; Yerli Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Oct; 77(3):630-7. PubMed ID: 20674475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the binding of oxovanadium(IV) to human serum albumin.
    Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T
    Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
    Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
    Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
    Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
    Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural study of the interaction of vanadate with the ligand 1,2-dimethyl-3-hydroxy-4-pyridinone (Hdmpp) in aqueous solution.
    Castro MM; Geraldes CF; Gameiro P; Pereira E; Castro B; Rangel M
    J Inorg Biochem; 2000 May; 80(1-2):177-9. PubMed ID: 10885483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxovanadium(IV)-catalysed oxidation of dibenzothiophene and 4,6-dimethyldibenzothiophene.
    Ogunlaja AS; Chidawanyika W; Antunes E; Fernandes MA; Nyokong T; Torto N; Tshentu ZR
    Dalton Trans; 2012 Dec; 41(45):13908-18. PubMed ID: 23023479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the antidiabetic capacity of the VO(dmpp)2 complex.
    Passadouro M; Metelo AM; Melão AS; Pedro JR; Faneca H; Carvalho E; Castro MM
    J Inorg Biochem; 2010 Sep; 104(9):987-92. PubMed ID: 20627316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanadium(V) compounds with the bis-(hydroxylamino)-1,3,5-triazine ligand, H2bihyat: synthetic, structural, and physical studies of [V2(V)O3(bihyat)2] and of the enhanced hydrolytic stability species cis-[V(V)O2(bihyat)]-.
    Nikolakis VA; Tsalavoutis JT; Stylianou M; Evgeniou E; Jakusch T; Melman A; Sigalas MP; Kiss T; Keramidas AD; Kabanos TA
    Inorg Chem; 2008 Dec; 47(24):11698-710. PubMed ID: 19006295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.